- Published on
Ophthalmology – Cataracts
Cataracts refer to any opacity of the crystalline lens and represent the most common cause of blindness worldwide. They are extremely prevalent with aging—nearly all individuals over 60 show some degree of lens opacity, and a significant proportion develop visually impairing cataracts as they age. In the United States, cataracts account for about half of low-vision cases in adults over 40, and their prevalence continues to rise with increasing life expectancy.
Cataract formation is influenced by multiple risk factors, including ultraviolet-B (UV-B) light exposure, smoking, radiation, oxidative stress, and certain medications such as corticosteroids. Systemic conditions like diabetes also increase risk. While a family history contributes, no single causative gene has been clearly identified for age-related cataracts. Preventive strategies focus on modifiable risks, such as smoking cessation, use of UV-blocking sunglasses, and management of systemic diseases like diabetes.
Pathophysiologically, cataracts are classified based on their location within the lens: nuclear (central), cortical (peripheral), posterior subcapsular (back of the lens), or mixed. Over time, biochemical and structural changes in lens proteins lead to loss of transparency. The progression is typically gradual, although the rate varies depending on the underlying cause.
The most common etiology is age-related degeneration. However, cataracts may also be congenital, traumatic, or associated with ocular diseases such as uveitis or glaucoma. Systemic diseases (e.g., diabetes, galactosemia), genetic syndromes (e.g., Down syndrome, Marfan syndrome), infections (e.g., congenital rubella), and environmental exposures (e.g., radiation, medications) are also recognized causes.
Clinically, patients present with progressive, painless vision loss that may affect one or both eyes. Symptoms often include glare, especially with bright lights or night driving, decreased contrast sensitivity, and diminished color perception. The specific symptoms can vary depending on the cataract type—for example, posterior subcapsular cataracts often cause early glare and difficulty with near vision.
A comprehensive eye examination is essential for diagnosis. This includes visual acuity testing, refraction, intraocular pressure measurement, and slit-lamp examination to identify the type and severity of lens opacity. Fundus examination is performed to assess retinal health, though visualization may be limited in advanced cataracts. If the posterior segment cannot be visualized, B-scan ultrasonography is used to rule out underlying pathology. Additional tests such as optical coherence tomography (OCT) may help detect coexisting macular disease.
Management depends on the degree of visual impairment and its impact on daily activities. In early stages, updating glasses or using brighter lighting may suffice. Pharmacologic dilation (mydriasis) may temporarily improve vision in select cases. However, definitive treatment is surgical.
Cataract surgery—most commonly via phacoemulsification—is one of the most successful and commonly performed procedures worldwide. It involves emulsifying and removing the opacified lens and replacing it with an artificial intraocular lens (IOL). Advances in IOL technology allow for correction of refractive errors, including astigmatism (toric lenses) and presbyopia (multifocal or accommodating lenses), reducing dependence on glasses.
Postoperatively, patients are typically treated with topical antibiotics, corticosteroids, and nonsteroidal anti-inflammatory drugs. Follow-up includes early postoperative evaluation within 24–48 hours and subsequent visits to assess healing and refractive outcomes. A common late complication is posterior capsule opacification (PCO), which can be effectively treated with Nd:YAG laser capsulotomy.
The prognosis after cataract surgery is excellent. Approximately 85–90% of patients achieve 20/40 vision or better, and outcomes are even better in the absence of other ocular diseases. Surgery significantly improves quality of life and reduces the risk of falls in older adults. However, complications—though uncommon—can include infection (endophthalmitis), retinal detachment, cystoid macular edema, and intraocular lens-related issues.
Overall, cataracts are a highly treatable condition, and timely surgical intervention can restore vision and significantly enhance daily functioning and quality of life.
Cataracts refer to any opacity of the crystalline lens and represent the most common cause of blindness worldwide. They are extremely prevalent with aging—nearly all individuals over 60 show some degree of lens opacity, and a significant proportion develop visually impairing cataracts as they age. In the United States, cataracts account for about half of low-vision cases in adults over 40, and their prevalence continues to rise with increasing life expectancy.
Cataract formation is influenced by multiple risk factors, including ultraviolet-B (UV-B) light exposure, smoking, radiation, oxidative stress, and certain medications such as corticosteroids. Systemic conditions like diabetes also increase risk. While a family history contributes, no single causative gene has been clearly identified for age-related cataracts. Preventive strategies focus on modifiable risks, such as smoking cessation, use of UV-blocking sunglasses, and management of systemic diseases like diabetes.
Pathophysiologically, cataracts are classified based on their location within the lens: nuclear (central), cortical (peripheral), posterior subcapsular (back of the lens), or mixed. Over time, biochemical and structural changes in lens proteins lead to loss of transparency. The progression is typically gradual, although the rate varies depending on the underlying cause.
The most common etiology is age-related degeneration. However, cataracts may also be congenital, traumatic, or associated with ocular diseases such as uveitis or glaucoma. Systemic diseases (e.g., diabetes, galactosemia), genetic syndromes (e.g., Down syndrome, Marfan syndrome), infections (e.g., congenital rubella), and environmental exposures (e.g., radiation, medications) are also recognized causes.
Clinically, patients present with progressive, painless vision loss that may affect one or both eyes. Symptoms often include glare, especially with bright lights or night driving, decreased contrast sensitivity, and diminished color perception. The specific symptoms can vary depending on the cataract type—for example, posterior subcapsular cataracts often cause early glare and difficulty with near vision.
A comprehensive eye examination is essential for diagnosis. This includes visual acuity testing, refraction, intraocular pressure measurement, and slit-lamp examination to identify the type and severity of lens opacity. Fundus examination is performed to assess retinal health, though visualization may be limited in advanced cataracts. If the posterior segment cannot be visualized, B-scan ultrasonography is used to rule out underlying pathology. Additional tests such as optical coherence tomography (OCT) may help detect coexisting macular disease.
Management depends on the degree of visual impairment and its impact on daily activities. In early stages, updating glasses or using brighter lighting may suffice. Pharmacologic dilation (mydriasis) may temporarily improve vision in select cases. However, definitive treatment is surgical.
Cataract surgery—most commonly via phacoemulsification—is one of the most successful and commonly performed procedures worldwide. It involves emulsifying and removing the opacified lens and replacing it with an artificial intraocular lens (IOL). Advances in IOL technology allow for correction of refractive errors, including astigmatism (toric lenses) and presbyopia (multifocal or accommodating lenses), reducing dependence on glasses.
Postoperatively, patients are typically treated with topical antibiotics, corticosteroids, and nonsteroidal anti-inflammatory drugs. Follow-up includes early postoperative evaluation within 24–48 hours and subsequent visits to assess healing and refractive outcomes. A common late complication is posterior capsule opacification (PCO), which can be effectively treated with Nd:YAG laser capsulotomy.
The prognosis after cataract surgery is excellent. Approximately 85–90% of patients achieve 20/40 vision or better, and outcomes are even better in the absence of other ocular diseases. Surgery significantly improves quality of life and reduces the risk of falls in older adults. However, complications—though uncommon—can include infection (endophthalmitis), retinal detachment, cystoid macular edema, and intraocular lens-related issues.
Overall, cataracts are a highly treatable condition, and timely surgical intervention can restore vision and significantly enhance daily functioning and quality of life.
0 Comments
